Yüklüyor......
Effect of an oral gold compound, auranofin, on non-specific bronchial hyperresponsiveness in mild asthma.
BACKGROUND--A recent double blind clinical trial in Japan has shown that auranofin (6 mg/day) is a useful treatment for patients with moderate to severe asthma. To investigate the mechanism of action of auranofin the bronchial responsiveness to inhaled methacholine has been studied in well controlle...
Kaydedildi:
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
1994
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC475050/ https://ncbi.nlm.nih.gov/pubmed/8066558 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|